These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9148185)

  • 1. [Report on satellite symposium on interferon beta therapy in multiple sclerosis, Newcastle on Tyne (England), June 26, 1996].
    Cendrowski W
    Neurol Neurochir Pol; 1996; 30(5):879-80. PubMed ID: 9148185
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comments on satellite symposium on the treatment of patients with multiple sclerosis with interferon-beta-1b, Munich (Germany), June 19, 1995].
    Cendrowski W
    Neurol Neurochir Pol; 1995; 29(6):979-80. PubMed ID: 8714735
    [No Abstract]   [Full Text] [Related]  

  • 3. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Report from the Satellite Symposium: Leading the way: outstanding efficacy of interferon beta-1b right from the start. Berlin, Germany, 06.24.2002].
    Cendrowski W
    Neurol Neurochir Pol; 2002; 36(6):1260-3. PubMed ID: 12715704
    [No Abstract]   [Full Text] [Related]  

  • 5. [Satellite decade symposium of achievements and the future of multiple sclerosis treatment. 19. Congress ECTRIMS, Mediolan (Italy), September 19, 2003].
    Cendrowski W
    Neurol Neurochir Pol; 2004; 38(1):73-4. PubMed ID: 15049175
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Time is brain' also in multiple sclerosis.
    Freedman MS
    Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
    [No Abstract]   [Full Text] [Related]  

  • 7. The curious incident of disability in multiple sclerosis trials.
    Coles A
    Lancet Neurol; 2006 Nov; 5(11):899-900. PubMed ID: 17052654
    [No Abstract]   [Full Text] [Related]  

  • 8. The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
    Duddy M; Palace J
    Pract Neurol; 2016 Feb; 16(1):4-6. PubMed ID: 26430247
    [No Abstract]   [Full Text] [Related]  

  • 9. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G; Horowski R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon beta treatment of multiple sclerosis.
    Pachner AR
    Neurology; 1994 Jan; 44(1):188; author reply 188-90. PubMed ID: 8290075
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of interferon beta in relapsing-remitting multiple sclerosis.
    Etheridge LJ; Beverley DW; Ferrie C; McManus E
    Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM; Peppler R; VanderBrug Medendorp S; Lehmann P; Alam J
    Ann Neurol; 1996 Oct; 40(4):618-27. PubMed ID: 8871582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon beta treatment of multiple sclerosis.
    McDonald MA; McDonald CM
    Neurology; 1994 Jan; 44(1):187. PubMed ID: 8290071
    [No Abstract]   [Full Text] [Related]  

  • 14. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
    McDonald WI; Miller DH; Thompson AJ
    Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon beta treatment of multiple sclerosis.
    Klapper JA
    Neurology; 1994 Jan; 44(1):188; author reply 188-90. PubMed ID: 8290074
    [No Abstract]   [Full Text] [Related]  

  • 16. Sjögren's syndrome with central nervous system involvement presenting as multiple sclerosis with failure response to beta-interferon.
    Tsai KY; Tsai CP; Liao N
    Eur Neurol; 2001; 45(1):59-60. PubMed ID: 11150847
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon beta treatment of multiple sclerosis.
    Longstreth WT; Franklin GM
    Neurology; 1994 Jan; 44(1):187; author reply 188-90. PubMed ID: 8290072
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-beta 1b: new hope for multiple sclerosis.
    Holdcroft C
    Nurse Pract; 1994 Jan; 19(1):6. PubMed ID: 8139804
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple sclerosis. Blurred vision.
    Bryan J
    Health Serv J; 1998 Jun; 108(5610):suppl 21-4. PubMed ID: 10180426
    [No Abstract]   [Full Text] [Related]  

  • 20. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.
    Montalban X; Sastre-Garriga J; Tintoré M; Brieva L; Aymerich FX; Río J; Porcel J; Borràs C; Nos C; Rovira A
    Mult Scler; 2009 Oct; 15(10):1195-205. PubMed ID: 19797261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.